243 related articles for article (PubMed ID: 30737713)
1. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.
Meijer D; de Jong D; Pansuriya TC; van den Akker BE; Picci P; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2012 Oct; 51(10):899-909. PubMed ID: 22674453
[TBL] [Abstract][Full Text] [Related]
3. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.
Emori M; Nakahashi N; Takasawa A; Murata K; Murahashi Y; Shimizu J; Tsukahara T; Sugita S; Takada K; Hasegawa T; Osanai M; Iba K
Hum Cell; 2023 Nov; 36(6):2195-2203. PubMed ID: 37454032
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
Kito F; Oyama R; Sakumoto M; Shiozawa K; Qiao Z; Toki S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.
Li X; Dean DC; Ferreira A; Nelson SD; Hornicek FJ; Yu S; Duan Z
Cancer Control; 2021; 28():10732748211045274. PubMed ID: 34767468
[TBL] [Abstract][Full Text] [Related]
9. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Lucas CG; Grenert JP; Horvai A
Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of NCC-DDLPS1-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sei A; Takeshita F; Sugaya J; Fukushima S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Jan; 34(1):260-270. PubMed ID: 32949334
[TBL] [Abstract][Full Text] [Related]
11. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
[TBL] [Abstract][Full Text] [Related]
12. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1.
Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Endo M; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 May; 54(5):392-399. PubMed ID: 29626278
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2020 Oct; 33(4):1321-1328. PubMed ID: 32815117
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Fukushima S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 May; 34(3):1008-1018. PubMed ID: 33677797
[TBL] [Abstract][Full Text] [Related]
15. Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone.
van Oosterwijk JG; de Jong D; van Ruler MA; Hogendoorn PC; Dijkstra PD; van Rijswijk CS; Machado I; Llombart-Bosch A; Szuhai K; Bovée JV
BMC Cancer; 2012 Aug; 12():375. PubMed ID: 22928481
[TBL] [Abstract][Full Text] [Related]
16. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
17. Distinct IDH1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract][Full Text] [Related]
18. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Akiyama T; Sugaya J; Nakatani F; Kojima N; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):384-391. PubMed ID: 34665443
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a novel cell line, NCC-DDLPS2-C1, derived from a patient with dedifferentiated liposarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 May; 34(3):990-997. PubMed ID: 33555519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
